News

Alvesco (Ciclesonide) is a novel inhaled corticosteroid (ICS) for the treatment of adults suffering from persistent asthma. ICSs are considered to be the foundation of asthma treatment and

Menactra vaccine is the first quadrivalent conjugate vaccine licensed in the US for the prevention of meningococcal disease and is designed to offer protection against four serogroups of

Mevacor inhibits an early step in the lead-up to cholesterol, the conversion of HMG-CoA to mevalonate. The Mevacor (lovastatin) proposal, submitted for review by Merck and Johnson and

The molecular target is one of several ion channel targets Icagen has identified for the treatment of pain. The Icagen/Abbott collaboration in pain, which began in 2001, provided

Emergent BioSolutions and the Health Protection Agency (HPA) are both leaders in biodefense vaccines, with long-established capabilities in the prevention of botulism dating back to the 1950s. In

Avastin is now approved for the first-line treatment of patients with metastatic carcinoma of the colon or rectum in combination with the chemotherapy regimens of intravenous 5-fluorouracil/folinic acid

Osmotics Pharma (OPI) has the exclusive worldwide rights covering technologies developed by the University of California and Brigham Young University. Applications of these technologies are currently being tested

Shire previously announced a pending suit against Impax based on Impax’s notice letter for a 30mg generic version of Adderall XR. Shire has now filed a second complaint

The first gene, involved in copying DNA, was linked specifically to pancreatic and ovarian cancers, which are notoriously hard to diagnose at an early stage. It could help